Protecting Your Kidneys: An update on SGLT-2 Inhibitors

1. Define the potential mechanism underlying the renoprotective effect of SGLT-2 Inhibitor therapy
2. Recognize the value of SGLT-2 inhibitors in delaying onset and progression of CKD with or without diabetes
3. Discuss the safety and efficacy data of recent trials on renal benefits of SGLT-2 inhibitors with or without diabetes

6:00 p.m. to 6:10 p.m.            Welcome & Pre-test

6:10 p.m. to 6:50 p.m.            Program Presentation

6:50 p.m. to 7:00 p.m.           Post-test and Q&A

Program components are:

• Pre-test
  
• Presentation
• Post-test

Achieving a passing score of the assessment post-test is not a requirement of obtaining continuing education credit; however participating in all active learning components is.

Ruth Ngwu, PharmD

PGY1 Community-Based Pharmacy Resident

UBSPPS/Middleport Family Health

General Registration $25.00

We reserve the right to cancel this program due to such factors as insufficient registration. Registrants will be notified in this case. Requests for refunds, minus a $10 service charge, must be in writing and will be honored up to one week prior to the program. After that time, no refunds will be provided.

Accreditaton information for pharmacists:

The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity has been awarded 1 contact hour or 0.1 ceu of live continuing pharmacy education credit.  Credit will be uploaded to the CPE Monitor for attendees who complete all components of the activity.

Protecting Your Kidneys: An update on SGLT-2 Inhibitors

ACPE#0044-0000-20-063-L01-P, 1 Contact Hr. or 0.1 ceu

Please email questions to pharmacyce@buffalo.edu